Table 1 Distribution of patients by pre-existing therapies and the bimatoprost therapy regimen in the study, ITT population
Baseline therapy | Bimatoprost therapy in the studya | |
|---|---|---|
Bimatoprost monotherapy | Bimatoprost combination therapy (2–3 types) | |
None | 89 (33.8%) | NA |
Group A | ||
PG monotherapy | 33 (12.5%) | NA |
Group B | ||
PG combination therapy | NA | 18 (6.8%) |
Group D | ||
Non-PG monotherapy or combination therapy | 67 (25.5%) | 33 (12.5%) |
| Â | Group C | Group E |